| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.25 | 9e-11 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |